Sunview proposes private placement to raise RM19mil


KUALA LUMPUR: Sunview Group Bhd has proposed a private placement of up to 10% of its issued share capital to raise funds mainly for working capital to support its engineering, procurement, construction and commissioning (EPCC) projects.

In a filing with Bursa Malaysia, Sunview said the private placement will involve the issuance of up to 56.77 million new shares to third-party investors to be identified later.

Based on an illustrative issue price of 33.5 sen per share, the exercise is expected to raise gross proceeds of up to RM19.02mil.

Sunview said the issue price will be fixed later at a discount of not more than 10% to the five-day volume-weighted average market price prior to the price-fixing date.

It said about RM18.52mil of the proceeds will be used for working capital for its EPCC projects, including the purchase of solar-related materials, payments to subcontractors and operating expenses.

The remaining RM500,000 will be used to cover estimated placement expenses.

Sunview noted that since its ACE Market listing in 2022, it has completed two fundraising exercises in 2024, raising a combined RM55.75mil.

Together with IPO proceeds of RM34.22mil, all funds raised to date have been fully utilised.

Sunview said the board considers the private placement to be the most suitable fundraising option as it allows the group to raise funds without incurring interest costs, strengthens its capital base and improves share liquidity.

The private placement is subject to approval from Bursa Securities for the listing and quotation of the new shares.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Sunview , private placement , EPCC ,

Next In Business News

Ringgit ends higher versus greenback
New units likely to lift Exsim Hospitality earnings
Banker�who helped lead Saudi debt boom will now drive FDI push
99 Speed Mart to sustain robust growth
Automotive sales up by 27% in January
Bursa Malaysia edges higher ahead of CNY
Mida’s IMFC�resolves over 44,000 investor cases
Duopharma wins RM118mil govt contracts
Trade likely to surpass 2025’s record
Steady orders likely for Wentel despite ringgit gains

Others Also Read